论文部分内容阅读
目的观察奥美拉唑与血凝酶联合治疗上消化道出血患者的临床效果。方法选取医院消化内科收治的上消化道出血患者118例作为研究对象,随机分为观察组和对照组,每组59例。观察组给予奥美拉唑与血凝酶联合治疗,对照组单纯给予奥美拉唑治疗,观察比较2组患者临床疗效、止血效果。结果观察组治疗总有效率为98.31%,高于对照组的88.14%(P<0.05)。观察组6 h止血的例数为47例(79.66%),多于对照组的26例(44.07%)(P<0.01);观察组平均止血时间为(9.74±2.15)h,短于对照组的(11.25±2.34)h(P<0.01)。结论奥美拉唑与血凝酶联合治疗上消化道出血患者临床效果显著,止血疗效明显,快速、安全,并发症较少,值得在临床治疗中广泛应用。
Objective To observe the clinical effect of omeprazole combined with hemagglutinin in the treatment of patients with upper gastrointestinal bleeding. Methods A total of 118 patients with upper gastrointestinal bleeding admitted to Department of Gastroenterology of Hospital were enrolled in this study. They were randomly divided into observation group and control group, 59 cases in each group. The observation group was treated with omeprazole and hemagglutinin, while the control group was treated with omeprazole alone. The clinical curative effect and hemostatic effect of the two groups were observed and compared. Results The total effective rate of observation group was 98.31%, higher than that of control group (88.14%) (P <0.05). The number of hemostasis cases in observation group was 47 cases (79.66%) in 6 h, more than 26 cases (44.07%) in control group (P <0.01). The mean bleeding time in observation group was (9.74 ± 2.15) h, shorter than that in control group (11.25 ± 2.34) h (P <0.01). Conclusion The combination of omeprazole and hemagglutinin in the treatment of upper gastrointestinal bleeding patients with significant clinical effect, hemostatic effect is obvious, fast, safe, less complications, it is worth widely used in clinical treatment.